CryoCath Technologies Inc. To Present At CIBC World Markets 16th Annual Healthcare Conference

MONTREAL, Nov. 3 /PRNewswire-FirstCall/ - CryoCath Technologies Inc. , today announced that Steven Arless, President & Chief Executive Officer of the Company, will present at the CIBC World Markets 16th Annual Healthcare Conference in New York on November 7, 2005 at 4.30pm ET.

A live webcast of the presentation will be available on CryoCath's website at www.cryocath.com on the Investors Page under Recent Financial Reports and Events. Please connect at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above website for 30 days.

About CryoCath(R)

CryoCath - www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter and surgical products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias and has development projects for the treatment of cardiac ischemia (angina) and peripheral arterial disease (PAD).

This press release includes "forward looking statements" that are subject to risks and uncertainties. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's Annual Report under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.

CryoCath Technologies Inc.

CONTACT: visit our website at www.cryocath.com, or contact Steven G.Arless, President & CEO, CryoCath Technologies Inc., Tel: (514) 694-1212ext. 224, sarless@cryocath.com; Mike Polonsky, Investor Relations, Tel:(416) 815-0700 ext. 231, Fax: (416) 815-0080, mpolonsky@equicomgroup.com

MORE ON THIS TOPIC